Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 86.40% | 85.35% | -946.55% | -2,984.87% | -4,078.57% |
| Total Depreciation and Amortization | -99.95% | -97.93% | -53.15% | 98.76% | 259,730.00% |
| Total Amortization of Deferred Charges | 3,292.59% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -88.70% | -88.66% | 28,218.32% | 3,732.49% | 2,299.15% |
| Change in Net Operating Assets | 1,525.63% | 394.27% | 205.90% | 225.55% | -132.92% |
| Cash from Operations | 80.60% | 80.17% | 60.14% | 22.57% | -650.01% |
| Capital Expenditure | -- | -- | -41.60% | -41.60% | -43.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 200.00% | 200.00% | 200.00% |
| Cash from Investing | -- | -- | 100.00% | 100.00% | 99.64% |
| Total Debt Issued | 114.44% | -- | 242.40% | -189.16% | -195.18% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,041.00% | -87.16% | -87.62% | -92.77% | -98.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.81% | -661.58% | -192.48% | -197.88% | -200.63% |